Systemic sclerosis (SSc) is a rare autoimmune disease characterized by fibroproliferative
alterations of the microvasculature leading to fibrosis and loss of function of the skin and …

In patients with systemic sclerosis (SSc), gastrointestinal (GI)-tract involvement is almost
universal. Any segment of the GI tract from mouth to anus can be involved, and GI symptoms …

Here, we provide important updates pertaining to the risk stratification, assessment,
diagnosis and management of SSc patients with gastrointestinal symptoms. These findings …

Nearly all patients with systemic sclerosis (SSc) are negatively affected by dysfunction in the
gastrointestinal tract, and the severity of gastrointestinal disease in SSc correlates with high …

Background Gastrointestinal tract (GIT) involvement is a common cause of debilitating
symptoms in patients with systemic sclerosis (SSc). There are no disease modifying …

Systemic sclerosis (SSc) is a chronic, multisystem connective tissue, and autoimmune
disease with the highest case-specific mortality and complications among rheumatic …

Systemic sclerosis is an autoimmune disease characterized by vasculopathy, progressive
fibrosis of the skin, and internal organ dysfunction. Gastrointestinal (GI) disease is the most …

The gastrointestinal (GI) tract is the most frequently involved internal organ in systemic
sclerosis (SSc), affecting more than 90% of patients. 1 The most frequent GI involvement is …

Systemic sclerosis (SSc) is a chronic systemic disease characterized by microvasculopathy,
autoantibodies, and extensive fibrosis. Intestinal involvement is frequent in SSc and …

Gastrointestinal dysmotility in systemic sclerosis (SSc) is associated with autoantibodies
against muscarinic-3 receptor (M3-R). We investigated the temporal course of the site of …